Decision-Aiding System Improves Clinical Trial Performance
The CCI-CPP collaborative team announces the newest release of Country Allocation Planner? (CAP), a Web-based system for global clinical trial planning.??
DECISION-AIDING SYSTEM IMPROVES CLINICAL TRIAL PERFORMANCE
ATLANTA, GA June 19, 2008 – The CCI-CPP collaborative team announces the newest release of Country Allocation Planner™ (CAP), a Web-based system for global clinical trial planning. CAP improves clinical trial enrollment forecasting and the process of selecting countries for study participation by facilitating robust, unlimited and real-time “what if” scenario modeling.
“Fundamentally, CAP helps study planning teams forecast realistic enrollment times and select the optimum mix of countries and subject contributions to meet key operational objectives, like cycle time and cost,” says Beth Harper of Clinical Performance Partners, Inc.
The design for the system is a result of a collaborative effort between Core Concept, Inc., specialists in software, simulation and decision support, and Clinical Performance Partners, Inc. a provider of enrollment and site performance management services. CAP uses industry data on disease prevalence as well as internal company benchmark data, and then incorporates enrollment feasibility data to plan, manage and update enrollment projections.
CAP’s linear programming and advanced data modeling capabilities allow planning across multiple parameters, such as number of countries and investigative sites, enrollment rate, subject contribution, disease prevalence, and per subject cost. This breadth of enrollment planning is generally not feasible for most users engaged in global clinical trials.
“Our user-friendly system ensures that all available information and advanced analysis techniques are combined to provide the sponsor or contract research organization (CRO) with insight into the best possible scenarios for enrollment success,” states Rob Andes, Executive Vice President of Core Concept. CAP does not make decisions, rely on team assumptions to make arbitrary enrollment projections or force the user to adhere to a set workflow.
Want to learn more or schedule a demo? Contact Rob Andes at 678/772-7181 or email [email protected].
About Clinical Performance Partners - CPP is a consulting firm dedicated to designing and implementing innovative and practical solutions for improving site performance and accelerating clinical trials results for the Life Sciences Industry. www.clinicalperformancepartners.com
About Core Concept, Inc. – CCI is a software product company specializing in the development of advanced decision support systems for the analysis, forecasting, planning and management of clinical trials and payor management. www.coreconcept.com
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
